385TiP - RIBOB: A study on the efficacy and safety of ribociclib in combination with letrozole in older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior systemic therapy for advanced disease
| Autor: | Kenis, C., Ponde, N.F., Decoster, L., de Azambuja, E., Jerusalem, G., Neven, P., Dal Lago, L., Denys, H., Vuylsteke, P., Duhoux, F.P., Wildiers, H. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v140-v140 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|